drugset / Trial / NCT06081049

The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)

NCT06081049

Phase 2 Unknown 152 enrolled Tor Biering-Sørensen
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effects of colchicine on heart failure related health status, quality of life, and vascular and cardiac function in patients with heart failure with preserved ejection fraction (HFpEF).

Timeline

Start
2024-01-18
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg